Industrial capability scaling in the sensory materials sector has marked a new corporate milestone. Givaudan has finalized a strategic equity investment in Microcaps AG, a high-tech spin-off originating from ETH Zurich’s Complex Materials Group. While specific financial terms of the transaction remain undisclosed, the joint venture is structurally organized to accelerate advanced performance diagnostics in personal care matrices.
Encapsulation technology remains an essential chemical vector for enhancing raw fragrance longevity, mitigating volatile degradation, and improving long-lasting olfactory delivery across fine perfume, beauty, and home care segments. Microcaps’ newly commercialized and patented "Perfume Pearls" matrix solves a historical industry challenge by enabling stable, high-performance fragrance delivery within completely alcohol-free aqueous systems.
Scaling Industrial Microfluidic Encapsulation Standards
Holding intellectual property across encapsulation hardware and premium ingredient formulations, Microcaps aims to deploy the world's first industrial-scale microfluidic processing line. Key technical and structural advantages of the partnership include:
Precision Mono-Dispersity: The microfluidic mechanism ensures uniform capsule shell architecture and size distribution, providing predictable, linear compound release curves.
Alcohol-Free Optimization: Empowers fine fragrance lines to retain traditional volatile performance and scent geometry without relying on volatile organic compounds (VOCs) or alcohol carriers.
Cross-Category R&D: The technical integration will extend from liquid fine fragrances into multi-phase emulsions, smart skincare formulations, and advanced personal hygiene products.
Corporate Management on Technical Synergy
Jeremy Compton, Global Head of Science & Technology Fragrances at Givaudan:
Encapsulation is one of the most transformative technologies in our field. By combining Givaudan’s deep expertise in fragrance creation with Microcaps’ breakthrough technologies, we can explore new ways to enhance performance and sustainability across many applications.
Dr. Alessandro Ofner and Michael Hagander, Founders and Co-CEOs of Microcaps AG:
This collaboration allows us to scale our technology and bring scientific precision to a wider market. Working together with Givaudan opens new doors for innovation, allowing us to redefine what high-precision encapsulation means for the global beauty industry.
